TOXINS AND ANTITOXINS 301 



Howitt, B. F., Shaw, E. B., Thelander, H., and Limper, M.: The Immuniza- 

 tion of Goats and Slieep to Poliomyelitis Virus : Clinical Application 

 of Their Serums, J. A. M. A. 96: 1280, 1931. 



Hunt, L. W.: The Treatment of Scarlet Fever With Antitoxin, J. A. M. A. 

 101: 14-44, 1933. 



Hurxthal, L. M. : Sterile Meninjfitis Following Lumbar Puncture, J. A. M. 

 A. 100: 1489, 1933. 



.Tudd, E. S.: War Surgery, The Journal-Lancet 38: 617-620, 1918. 



.Tungeblut, C. W.: The Immunological Characteristics of the Poliocidal 

 Substance in Human Serum. Concentration, Thermo-stability, Ab- 

 soiption and Specificity, J. Immunol. 27: 17, 1934. 



.Tungeblut, C. W., Meyer, K., and Engle, E. T.: Inactivation of Poliomye- 

 litis Virus and of Diphtheria Toxin bv Various Endocrine Principles, 

 .1. Immunol. 27: 43, 1934. 



KMufViiiann, F., Mffrcli, E., and Scliniitli, K. : On llic Serology of the Pneumo- 

 coccus Group, J. Immunol. 39: .397, 1940. 



Karelitz, S., and Schick, B.: E])idemiologic Factors in Measles Prophylaxis, 

 J. A. M. A. 104: 991, 193.^. 



Kettle: (1919.) See Robertson and O'Brien, 1929. 



Kirkbride, M. B., and Wheeler, M. W. : Comparison of Reactions in In- 

 dividuals to Toxins Prepared From Three Strains of Scarlet Fever 

 Streptococci, Proc. Soc. Exper. Biol. & Med. 22: 85, 1924. 



Kolmer, .1. A.: Studies on the Preservation of Human Blood, Am. J. M. Sc. 

 200: 311, 1940. 



Kolmer, J. A., and Rule, A. M. : Concerning Vaccination of Monkeys 

 Against Acute Anterior Poliomyelitis. With Special Reference to 

 Oral Immunization, J. Immunol. 26: .505, 1934. 



Levine, M. I., Neal, J. B., and Park, W. H. : Relation of Physical Char- 

 acteristics to Susceptibility to Anterior Poliomyelitis, J. A. M, A. 

 100: 160, 1933. 



IFcCann, W. S.: The Serum Treatment of Erypsipelas, .1. A. M. A. 91: 78, 

 1928. 



McCoy, G. W.: Control and Standardization of Biological Products, Newer 

 Knowledge of Bacteriology and Immunology, Chicago, 1928, Univer- 

 sity of Chicago Press, p. 947. 



;^^cKhann, C. F., and Chu, Fu Tang: Antibodies in Placental Extracts, 

 J. Infect. Dis. 52: 268, 1933. 



Malcolm, W. G., and White, B.: Studies on Meningococcus I. Endotoxin, 

 J. Immunol. 23: 291, 1932. 



Meader, F. M.: Scarlet Fever Prophylaxis, J. A. M. A. 94: 622, 1930. 



Mehlman, J., and Seegal, B. C. : A Comparison of the Sensitizing and the 

 Therapeutic Effect of Rabbit and Horse Antipneumococcus Type I 

 Serums in Albino Mice, J. Immunol. 27: 81, 1934. 



Miller, R. H., and Rogers, H.: Present Status of Tetanus, J. A. M. A. 104; 

 186, 1935. 



l^folitch, M.: Prevention of Scarlet Fever, J. A. M. A. 102: 2021, 1934. 



JFurdick, P. P., and Cohen, S. M. : A Note on the Fractionation of Anti- 

 meningococcus Serum, J. Immunol. 24: 531, 1933. 



Neff, F. C: Scarlet Feyer Immunization, Arch. Pediat. 39: 250, 1922. 



Neufeld and Handel: (1910.) Cited by Dochez and Gillespie, 1913. 



Nevin, M. : Experimental Gas Gangrene, J. Infect. Dis. 25: 178, 1919. 



Olmstead, M.: An Antigenic Classification of the Group IV Pneumococci, 

 From the Presbyterian Hospital, New York Citv, J. Immunol. 2: 

 425, 1917. 



Oram, Florence: Pneumococcus Leucocidin, .1. Immunol. 26: 233, 1934. 



Orr, T. G.: Gas Bacillus Infection of Abdominal Wall, .1. A. M. A. 102: 

 2081. 1934. 



